June 25, 2026
Obleio Bio
Obleio Bio is a Cambridge, Mass.-based biotech focused on autoimmune disease.
- Round
- Series B
- Amount raised
- $62M
- Lead investor
- Pfizer Ventures
- Industry
- Biotechnology
- Headquarters
- Cambridge, United States
- Employees
- —
- Website
- —
- —
Other investors
- Deep Track Capital
- GV
- Aditum Bio
Source: Axios Pro Rata